BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 168.00% for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2026-08-31
- BIOMERICA INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2026 was 168.00%, a 43.09% increase from fiscal 2025.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2025 was 117.41%, a 4.85% increase from fiscal 2024.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2024 was 111.98%, a 10.03% increase from fiscal 2023.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2023 was 101.77%, a 3.52% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|
| 2026-05-31 | 168.00% 10-K · filed 2026-08-31 |
| 2025-05-31 | 117.41% 10-K · filed 2026-08-31 |
| 2024-05-31 | 111.98% 10-K · filed 2025-08-29 |
| 2023-05-31 | 101.77% 10-K · filed 2024-08-28 |
| 2022-05-31 | 105.48% 10-K · filed 2023-08-25 |
| 2013-05-31 | 70.70% 10-K · filed 2013-08-29 |
| 2012-05-31 | 84.97% 10-K · filed 2013-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |